CHICAGO/LONDON: With two COVID-19 vaccines now under scrutiny for possible links to very rare cases of blood clots in the brain, U.S. government scientists are focusing on whether the specific technology behind the shots may be contributing to the risk.
In Europe, health regulators said last week there was a possible link between the AstraZeneca Plc vaccine and 169 cases of a rare brain blood clot known as cerebral venous sinus thrombosis (CVST), accompanied by a low blood platelet count, out of 34 million shots administered in the European Economic Area.
The U.S. Food and Drug Administration on Tuesday recommended temporarily halting use of the Johnson & Johnson vaccine after reports of six cases of CVST in women under age 50 among some 7 million people who received the shot in the United States.
Both vaccines are based on a new technology using adenoviruses, which cause the common cold, that have been modified to essentially render them harmless. The viruses are employed as vectors to ferry instructions for human cells to make proteins found on the surface of the coronavirus, priming the immune system to make antibodies that fight off the actual virus.
Scientists are working to find the potential mechanism that would explain the blood clots. A leading hypothesis appears to be that the vaccines are triggering a rare immune response that could be related to these viral vectors, FDA officials said at a briefing on Tuesday.
The U.S. agency will analyze data from clinical trials of several vaccines using these viral vectors, including J&J's Ebola vaccine, to look for clues.
None of the previous vaccines using viral vectors have been administered at close to the scale of the AstraZeneca and J&J COVID-19 shots, which may explain why a potential link to blood clots only materialized during these massive vaccination programs.
The technology has also been used in coronavirus vaccines developed in China and Russia.
Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, was reluctant to declare the blood clot issues a "class effect" shared by all adenovirus vector vaccines, but he sees marked similarity in the cases.
"It's plainly obvious to us already that what we're seeing with the Janssen (J&J) vaccine looks very similar to what was being seen with the AstraZeneca vaccine," Marks said. "We can't make some broad statement yet, but obviously, they are from the same general class of viral vectors."
'AT THE BEGINNING'
In Europe, scientists are exploring a number of hypotheses, including looking more broadly at the way the SARS-CoV-2 virus itself affects blood coagulation.
One team in the Netherlands plans to conduct lab studies that expose specific types of cells and tissues to the vaccines and monitor how they react. They will also explore whether any risks could be limited further by reducing the vaccine dose.
"There are many hypotheses, and some of them may play a role," said Eric van Gorp, a virologist at Erasmus Medical Centre in Rotterdam. "We are at the beginning, and - as it goes in research - it may be that we can find the clue at once, or it may be that it goes step by step."
Other scientists were struck by the parallel between the J&J and AstraZeneca shots.
Danny Altmann, a professor of immunology at Imperial College London, said the similar blood clotting incidents associated with both "is clearly noteworthy for defining mechanism." There has been no sign of such problems with the vaccines made by BioNTech SE with Pfizer Inc or Moderna Inc using a different technology.
"It would be interesting to know more about Sputnik V - also a similar adenovirus vaccine," Altmann said. The Russian vaccine developed by the Gamaleya Institute in Moscow uses two different human cold viruses - including the Ad26 virus in the J&J shot.
The issue might also affect the adenovirus vector vaccine from China's CanSino Biological, experts said.
Examining whether there is some common link to adenoviruses is "a reasonable speculation, and it's a line of research and investigation. But that doesn't mean it's proven," said John Moore, a professor of microbiology and immunology at Weill Cornell Medical College in New York.
Moore, who took part in an informal White House briefing with other scientists on Tuesday, said the FDA and U.S. Centers for Disease Control and Prevention are working closely with health officials in Europe to determine whether the syndromes linked to the AstraZeneca and J&J vaccines are the same.
An important clue may lie in the fact that the reported events typically appear around 13 days after the shot, which is the period in which antibodies might be expected to appear.
"This is speculation, but the timing of something happening after about 13 days on average is suggestive of an immune response to a component to the vaccine," Moore said.
Investigations of this sort could take years. But like the vaccines themselves that were produced in record time, Moore believes there will be so much effort put into the research that it will more likely be resolved within weeks.
"It's so clearly important," he said.
Reuters
Wed Apr 14 2021
In Europe, health regulators said last week there was a possible link between the AstraZeneca Plc vaccine and 169 cases of a rare brain blood clot. REUTERSpic
Polis geledah pejabat pemimpin Parlimen Eropah di Brussels
Pihak berkuasa Jerman melakukan penggeledahan di pejabat seorang ahli Parlimen Eropah di Brussels pada Selasa.
Kereta Safiq Rahim diserang dua lelaki bermotosikal
Selang dua hari selepas pemain Selangor FC Faisal Halim diserang, Safiq Rahim pula ditimpa malang apabila cermin keretanya dipecahkan menggunakan tukul besi.
Balu Navalny gesa rakyat Rusia tidak putus asa
Balu kepada pemimpin pembangkang Rusia Alexei Navalny, Yulia Navalnaya menggesa rakyat negara itu supaya tidak berputus asa memerangi rejim selepas pelantikan Vladimir Putin.
Perhimpunan Agung PBB mengundi Jumaat ini
Ia secara berkesan akan bertindak sebagai tinjauan global mengenai berapa banyak sokongan rakyat Palestin terhadap bidaan mereka, yang telah diveto dalam Majlis Keselamatan PBB bulan lalu oleh Amerika Syarikat.
Serangan di Rafah satu kesilapan, malapetaka kemanusiaan - PBB
Setiausaha Agung PBB Antonio Guterres pada Selasa memberi amaran kepada Israel bahawa serangan ke atas Rafah akan menjadi kesilapan strategik, bencana politik dan kemanusian.
Kehadiran Agong ke Parlimen kukuhkan lagi hubungan dua hala
Di bawah pemerintahan Yang Di-Pertuan Agong, Sultan Ibrahim selaku Sultan Negeri Johor, hubungan negeri itu dengan Singapura semakin kukuh.
Ia dapat dilihat dari segi ekonomi dan hubungan antara rakyat.
Ia dapat dilihat dari segi ekonomi dan hubungan antara rakyat.
Vladimir Putin angkat sumpah sebagai Presiden bagi penggal kelima
Majlis angkat sumpah itu diadakan di Kremlin dengan diboikot Amerika Syarikat dan beberapa negara barat lain susulan perang antara Rusia-Ukraine.
Cuaca panas undang stres kalangan jemaah wanita
Dalam keadaan cuaca panas melampau dan untuk tempoh yang lama, ia boleh mengundang kepada stres atau tekanan sehingga berupaya menjejaskan kesihatan mental jemaah wanita yang menerima tawaran sebagai tetamu Allah di musim haji.
Mesyuarat JKKTN setuju perkukuh kawal selia BBP
Mesyuarat Jawatankuasa Khas Kabinet Tatakelola Nasional (JKKTN) yang bersidang hari ini bersetuju dengan cadangan memperkukuh kawal selia Badan Berkanun Persekutuan (BBP) melalui penggubalan akta.
Usaha bersepadu penting untuk mengekang jenayah
Usaha bersepadu di kalangan agensi-agensi dari pelbagai bidang adalah penting untuk mengekalkan kerangka keselamatan global, kata Menteri Dalam Negeri Datuk Seri Saifuddin Nasution Ismail.
Beliau menyatakan bahawa akses internet dan kemajuan teknologi telah membawa ancaman baru dan mengubah landskap keselamatan, oleh itu perlunya pendekatan yang bersatu padu untuk menangani mereka.
Beliau menyatakan bahawa akses internet dan kemajuan teknologi telah membawa ancaman baru dan mengubah landskap keselamatan, oleh itu perlunya pendekatan yang bersatu padu untuk menangani mereka.
Isu tunggakan cetakan MyKid bakal selesai Julai ini - JPN
Isu cetakan MyKid yang tertunggak akibat masalah perolehan bekalan mikrocip semasa pandemik COVID-19 lalu dijangka dapat diselesaikan pada Julai ini secara berperingkat di seluruh negara.
Program Jana Wibawa dilaksana selepas dapat persetujuan Jemaah Menteri - Saksi
Mahkamah Sesyen di sini hari ini diberitahu bahawa cadangan mengenai Jana Wibawa telah dibawa ke mesyuarat untuk pertimbangan sebelum Jemaah Menteri memutuskan supaya program itu diteruskan pada 2020.
Kelaparan akut jejaskan 281.6 juta orang tahun lepas - PBB
Tahap bahaya kelaparan akut menjejaskan 281.6 juta orang tahun lepas, tahun kelima berturut-turut bahawa ketakjaminan makanan semakin memburuk.
Hamilton optimis kedudukan lebih baik di GP China
Lewis Hamilton melihat potensi kedudukan yang lebih baik dalam saingan Grand Prix yang kembali ke China buat pertama kali dalam tempoh lima tahun, hujung minggu ini.
'Selfish!' - Fasha Sandha sedih raya di Perlis tak jadi gara-gara dijangkiti COVID-19
Fasha berkata dia mula melakukan pemeriksaan COVID-19 selepas berasa tidak sihat badan dan mengalami bersin tidak henti sejak Raya pertama.
Kes COVID-19 catat penurunan ketara pada ME 14/2024 - KKM
Jumlah kes COVID-19 menurun 97.1 peratus kepada 493 kes pada Minggu Epidemiologi ke-14 (ME 14/2024) iaitu bagi tempoh 31 Mac hingga 6 April lepas berbanding 17,256 kes pada ME 1/2024.
China jadikan pengalaman pencegahan COVID-19 untuk hadapi pandemik masa depan
China akan menjadikan pengalaman dalam pencegahan dan kawalan COVID-19 untuk membuat persediaan yang lebih proaktif untuk menghadapi pandemik masa depan seperti "Penyakit X".
Negara berdepan ketirisan subsidi diesel serius - Amir Hamzah
Negara kini sedang berdepan isu ketirisan subsidi diesel yang serius dan wujud kemungkinan terdapat pihak yang tidak layak masih menikmati subsidi itu, kata Menteri Kewangan II Datuk Seri Amir Hamzah.
Kematian akibat kemalangan jalan raya lebih tinggi daripada COVID-19 - Anthony Loke
PDRM akan mengeluarkan data mengenai kemalangan jalan raya pada setiap hari, bukan setahun sekali seperti diamalkan sebelum ini.
Ismail Sabri ziarah lapan beradik yatim piatu akibat COVID-19
Ismail Sabri tiba kira-kira jam 2 petang di kediaman lapan beradik itu di Taman Adenium, Bukit Beruntung pada Selasa.